New therapy aims to ease PTSD and brain injury symptoms in first responders

NCT ID NCT07212140

Not yet recruiting Symptom relief Sponsor: Florida State University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an adapted version of a therapy called STAIR-NT, designed to help first responders who have both PTSD and a history of traumatic brain injury. The therapy combines skills training and narrative therapy to address emotional regulation and interpersonal issues. Researchers will enroll 80 participants to see if the therapy reduces PTSD and anxiety symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Adapted STAIR-NT (Skills Training in Affective and Interpersonal Regulation with Narrative Therapy)
What this could lead to: If it works, this could point toward a tailored therapy that reduces PTSD and anxiety symptoms in first responders with a history of traumatic brain injury.
What could go wrong: This is a small, early pilot study (80 people) testing an adapted therapy. It may not show clear benefits, and results may not apply to all first responders.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD - POST TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic combat disorder post-traumatic stress disorder traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PTSD - POST TRAUMATIC STRESS DISORDER TBI (TRAUMATIC BRAIN INJURY)

Contacts and locations

Locations

Invisible Wounds Project

Forest Lake, Minnesota, 55025, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.